SODIUM TETRADECYL SULFATE Drug Patent Profile
Which patents cover Sodium Tetradecyl Sulfate, and what generic alternatives are available?
Sodium Tetradecyl Sulfate is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in SODIUM TETRADECYL SULFATE is sodium tetradecyl sulfate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the sodium tetradecyl sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sodium Tetradecyl Sulfate
A generic version of SODIUM TETRADECYL SULFATE was approved as sodium tetradecyl sulfate by HIKMA on December 9th, 2019.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SODIUM TETRADECYL SULFATE?
- What are the global sales for SODIUM TETRADECYL SULFATE?
- What is Average Wholesale Price for SODIUM TETRADECYL SULFATE?
Summary for SODIUM TETRADECYL SULFATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 11 |
| Patent Applications: | 1,929 |
| DailyMed Link: | SODIUM TETRADECYL SULFATE at DailyMed |
Recent Clinical Trials for SODIUM TETRADECYL SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Goldman, Butterwick, Fitzpatrick and Groff | PHASE4 |
| University of California, Los Angeles | NA |
| Goldman, Butterwick, Fitzpatrick and Groff | Phase 2 |
Medical Subject Heading (MeSH) Categories for SODIUM TETRADECYL SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for SODIUM TETRADECYL SULFATE
US Patents and Regulatory Information for SODIUM TETRADECYL SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | SODIUM TETRADECYL SULFATE | sodium tetradecyl sulfate | INJECTABLE;INJECTION | 209937-001 | Dec 9, 2019 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
